Welcome to LookChem.com Sign In|Join Free
  • or
1-N-Benzyl-proline, a chemical compound with the molecular formula C13H17NO2, is a derivative of the amino acid proline featuring a benzyl group attached to the nitrogen atom. This modification endows it with unique properties that have made it a valuable component in the synthesis of peptide-based drugs and pharmaceuticals, enhancing their biological activities. Its potential medicinal properties include antioxidant capabilities and enzyme inhibition, which have spurred research into its applications in treating neurological disorders, cancer, and viral infections, solidifying its significance in medicinal chemistry.

60169-72-4

Post Buying Request

60169-72-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60169-72-4 Usage

Uses

Used in Pharmaceutical Synthesis:
1-N-Benzyl-proline is used as a key component in the synthesis of peptide-based drugs, for its ability to improve the biological properties of these compounds, leading to enhanced therapeutic effects.
Used in Medicinal Chemistry Research:
1-N-Benzyl-proline is utilized as a subject of study in medicinal chemistry for its potential antioxidant properties and its capacity to inhibit certain enzymes, which could contribute to the development of new treatments for various diseases.
Used in Antioxidant Applications:
1-N-Benzyl-proline is used as an antioxidant in biological systems to protect cells from oxidative damage, which is crucial in the prevention and treatment of a range of diseases associated with oxidative stress.
Used in Enzyme Inhibition:
1-N-Benzyl-proline is employed as an enzyme inhibitor, potentially blocking the activity of enzymes involved in disease processes, thus offering a therapeutic approach to managing certain conditions.
Used in Neurological Disorder Treatment:
In the field of neurology, 1-N-Benzyl-proline is used as a potential treatment for neurological disorders, leveraging its biochemical properties to address the underlying mechanisms of such conditions.
Used in Cancer Therapy:
1-N-Benzyl-proline is used as a component in cancer research and treatment, with its potential to target and affect cancer cells, contributing to the development of novel anticancer therapies.
Used in Viral Infection Treatment:
In virology, 1-N-Benzyl-proline is investigated for its potential use in treating viral infections, possibly through its interaction with viral proteins or enzymes, offering a new avenue for antiviral drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 60169-72-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,1,6 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60169-72:
(7*6)+(6*0)+(5*1)+(4*6)+(3*9)+(2*7)+(1*2)=114
114 % 10 = 4
So 60169-72-4 is a valid CAS Registry Number.

60169-72-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name benzylproline

1.2 Other means of identification

Product number -
Other names Pyrrolidine,1-benzyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60169-72-4 SDS

60169-72-4Relevant academic research and scientific papers

Discovery of novel n-substituted prolinamido indazoles as potent rho kinase inhibitors and vasorelaxation agents

Yao, Yangyang,Li, Renze,Liu, Xiaoyu,Yang, Feilong,Yang, Ying,Li, Xiaoyu,Shi, Xiang,Yuan, Tianyi,Fang, Lianhua,Du, Guanhua,Jiao, Xiaozhen,Xie, Ping

, (2017/11/07)

Inhibitors of Rho kinase (ROCK) have potential therapeutic applicability in a wide range of diseases, such as hypertension, stroke, asthma and glaucoma. In a previous article, we described the lead discovery of DL0805, a new ROCK I inhibitor, showing potent inhibitory activity (IC50 6.7 μM). Herein, we present the lead optimization of compound DL0805, resulting in the discovery of 24- and 39-fold more-active analogues 4a (IC50 0.27 μM) and 4b (IC50 0.17 μM), among other active analogues. Moreover, ex-vivo studies demonstrated that 4a and 4b exhibited comparable vasorelaxant activity to the approved drug fasudil in rat aortic rings. The research of a preliminary structure-activity relationship (SAR) indicated that the target compounds containing a β-proline moiety have improved activity against ROCK I relative to analogues bearing an β-proline moiety, and among the series of the derivatives with a β-proline-derived indazole scaffold, the inhibitory activity of the target compounds with a benzyl substituent is superior to those with a benzoyl substituent.

Gas-phase fragmentation of the protonated benzyl ester of proline: Intramolecular electrophilic substitution versus hydride transfer

Li, Fei,Zhang, Xiaoping,Zhang, Huarong,Jiang, Kezhi

, p. 423 - 429 (2013/06/04)

In this study, the gas phase chemistry of the protonated benzyl esters of proline has been investigated by electrospray ionization mass spectrometry and theoretical calculation. Upon collisional activation, the protonated molecules undergo fragmentation reactions via three primary channels: (1) direct decomposition to the benzyl cation (m/z 91), (2) formation of an ion-neutral complex of [benzyl cation + proline]+, followed by a hydride transfer to generate the protonated 4,5-dihydro-3H-pyrrole-2-carboxylic acid (m/z 114), and (3) electrophilic attack at the amino by the transferring benzyl cation, and the subsequent migration of the activated amino proton leading to the simultaneous loss of (H2O + CO). Interestingly, no hydrogen/deuterium exchange for the fragment ion m/z 114 occurs in the d-labeling experiments, indicating that the transferring hydride in path-b comes from the methenyl hydrogen rather than the amino hydrogen. For para-substituted benzyl esters, the presence of electron-donating substituents significantly promotes the direct decomposition (path-a), whereas the presence of electron-withdrawing ones distinctively inhibits that channel. For the competing channels of path-b and path-c, the presence of electron-donating substituents favors path-b rather than path-c, whereas the presence of electron-withdrawing ones favors path-c rather than path-b. Copyright 2013 John Wiley & Sons, Ltd. Copyright

Palladium(II)-N-heterocyclic carbene complexes derived from proline: Synthesis and characterization

Tang, Yi-Qiang,Lu, Jian-Mei,Wang, Xiu-Ren,Shao, Li-Xiong

experimental part, p. 7970 - 7974 (2010/10/19)

Pd(II)-N-heterocyclic carbene complexes derived from proline have been successfully synthesized in good yields and their structures have been characterized by X-ray single crystal diffraction. It was found that the substituents on the N-atom of the pyrrolidine skeleton dramatically affect on the coordination pattern of the palladium complexes. In a word, when an electron-rich group as benzyl group was attached on the N-atom, both of the N-atom and NHC were coordinated to the Pd(II) center; while when an electron-poor group as Ts group was attached, a dimeric mono-coordinated Pd(II)-NHC was obtained exclusively.

Collection of traceable compounds and uses thereof

-

, (2010/07/06)

The use of a collection of compounds of general formula (I), wherein: n is 0 or 1; p represents an integer between 1 and 6; r represents an integer between 1 and 12; R1 and R′1 represent in particular a hydrogen atom; R2 represents an amino acid side chain or an amino acid derivative; R3 represents a group derived from a carboxylic acid, bearing a basic entity; R4 represents in particular an alkyl group containing 1 to 10 carbon atoms; and A represents a hydrogen atom, a protecting group or a tracing group, in particular a fluorophor, a coloring agent or a quencher, for determining, through binding studies, ligands of receptors whose ligand is unknown or whose ligand useful for carrying out specific affinity binding assays is unknown.

Use of Chloroalkenylamines for the Synthesis of 1-Azabicyclooctane and 1-Azabicyclononane Derivatives

Lochead, Alistair W.,Proctor, George R.,Caton, Michael P. L.

, p. 2477 - 2489 (2007/10/02)

Various N-(chloroprop-2-enyl)-, N-(3-chlorobut-2-enyl)-, N-(4-chloropent-3- and -4-enyl)-proline derivatives, -succinimides, and -phthalimides have been synthesised and subjected to Lewis acid treatment.The following gave fruitful results: N-(4-chloropent-3-enyl)-5-hydroxy-2-pyrrolidone (25) gave 1-acetyl-1,2,3,6,7,7a-hexahydropyrrolizin-5-one (28); N-(4-chloropent-3-enyl)-3-hydroxy-2,3-dihydro-1H-isoindol-1-one (30) gave 1-endo-acetyl-1,2,3,9b-tetrahydropyrroloisoindol-5-one (31) which was isomerised to the exo-isomer; N-(4-chloropent-3-enyl)-3-methylene-2,3-dihydro- 1H-isoindol-1-one (34) and N-(4-chloropent-3-enyl)-3-hydroxy-3-methyl-2,3-dihydro-1H-isoindol-1-one (33) gave 1-endo-acetyl-9b-methyl-1,2,3,9b-tetrahydropyrroloisoindol-5-one (35); N-proline (42) gave 8,9-dimethoxy-1,2,3,5,6,10b-hexahydropyrroloisoquinoline (43), N-(2-chloroprop-2-enyl)-2-(2-hydroxy-2-propyl)pyrrolidine (44) gave 6-chloro-8,8-dimethyl-1,2,3,5,8,8a-hexahydroindolizine (47) and 8,8-dimethyl-1,2,3,7,8,8a-hexahydroindolizin-6(5H)-one (48) which were reduced to the corresponding alcohols; N-(4-chloropent-4-enyl)-3-hydroxy-2,3-dihydro-1H-isoindol-1-one (50) gave 7,8,11,11a-tetrahydro-5H-azepinoisoindole-5,10(9H)-dione (51).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 60169-72-4